Australia markets closed

Beijing Balance Medical Technology Co.,Ltd. (688198.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
102.07-0.94 (-0.91%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 14.07B
Enterprise value 13.69B
Trailing P/E 127.17
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)37.57
Price/book (mrq)11.65
Enterprise value/revenue 35.84
Enterprise value/EBITDA 123.11

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3-9.48%
S&P500 52-week change 320.87%
52-week high 3144.00
52-week low 396.81
50-day moving average 3105.57
200-day moving average 3118.74

Share statistics

Avg vol (3-month) 3199.66k
Avg vol (10-day) 3158.86k
Shares outstanding 5136.58M
Implied shares outstanding 6136.59M
Float 835.37M
% held by insiders 174.08%
% held by institutions 110.56%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.78%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.78%
5-year average dividend yield 4N/A
Payout ratio 461.73%
Dividend date 3N/A
Ex-dividend date 428 May 2024
Last split factor 21.4:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 29.27%
Operating margin (ttm)-2.85%

Management effectiveness

Return on assets (ttm)4.37%
Return on equity (ttm)8.79%

Income statement

Revenue (ttm)382.01M
Revenue per share (ttm)2.77
Quarterly revenue growth (yoy)17.50%
Gross profit (ttm)N/A
EBITDA 99.52M
Net income avi to common (ttm)111.83M
Diluted EPS (ttm)0.81
Quarterly earnings growth (yoy)-28.90%

Balance sheet

Total cash (mrq)447.92M
Total cash per share (mrq)3.28
Total debt (mrq)11.3M
Total debt/equity (mrq)0.94%
Current ratio (mrq)10.47
Book value per share (mrq)8.84

Cash flow statement

Operating cash flow (ttm)111.65M
Levered free cash flow (ttm)-80.58M